Evaluating neoadjuvant therapy effectiveness on systemic disease: Use of a prostatic-specific membrane reverse transcription polymerase chain reaction
- 1 March 1997
- Vol. 49 (3) , 95-101
- https://doi.org/10.1016/s0090-4295(97)00175-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.Journal of Clinical Oncology, 1995
- Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNACancer, 1995
- Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous bloodCancer, 1995
- Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reactionBritish Journal of Cancer, 1995
- Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assayUrology, 1994
- Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.Journal of Clinical Oncology, 1994
- Circulating Prostate Specific Antigen‐positive Cells Correlate with Metastatic Prostate CancerBritish Journal of Urology, 1992
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Are breast cancer axillary node micrometastases worth detecting?The Journal of Pathology, 1990
- Detection of Minimal Residual Cells Carrying the t(14;18) by DNA Sequence AmplificationScience, 1987